These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 237390

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The treatment of ulcerative colitis.
    Truelove SC.
    Schweiz Med Wochenschr; 1981 Sep 12; 111(37):1342-6. PubMed ID: 6117123
    [Abstract] [Full Text] [Related]

  • 3. [Experience in the treatment of nonspecific ulcerative colitis].
    Karnaukhov VK.
    Sov Med; 1973 May 12; 36(5):93-7. PubMed ID: 4148970
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Conservative treatment of ulcerative colitis: late results.
    Nicolaidis C, Kalliterakis E, Kralios N, Antoniou C.
    Proc R Soc Med; 1969 Mar 03; 62(3):262. PubMed ID: 4388780
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ulcerative colitis and its treatment.
    Jacknowitz AI.
    Am J Hosp Pharm; 1980 Dec 03; 37(12):1635-46. PubMed ID: 6108713
    [Abstract] [Full Text] [Related]

  • 13. [Oral therapy with Azulfidine/Salazopyrin in ulcerative colitis].
    Truelove SC.
    Z Gastroenterol Verh; 1981 Jun 03; 19():33-5. PubMed ID: 6168131
    [No Abstract] [Full Text] [Related]

  • 14. Maintenance of remission in ulcerative colitis. Effect of an orally absorbed mast cell stabilizer.
    Davies PS, Rhodes J, Counsell B, Evans BK.
    Am J Gastroenterol; 1980 Aug 03; 74(2):150-3. PubMed ID: 6108711
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic experience with ulcerative colitis and Crohn disease].
    Nagy G, Prónay G, Ujszászy L.
    Orv Hetil; 1985 Jan 06; 126(1):17-20, 23-4. PubMed ID: 2857480
    [No Abstract] [Full Text] [Related]

  • 16. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA.
    Compr Ther; 1985 Dec 06; 11(12):14-9. PubMed ID: 2866866
    [Abstract] [Full Text] [Related]

  • 17. Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group.
    Rijk MC, van Lier HJ, van Tongeren JH.
    Am J Gastroenterol; 1992 Apr 06; 87(4):438-42. PubMed ID: 1348159
    [Abstract] [Full Text] [Related]

  • 18. [Immunosuppressive therapy in ulcerative rectocolitis. Long-term assessment of results].
    Aresu G, Mereu S, Frongia N, Casula G, Uccheddu A.
    Minerva Med; 1982 Apr 02; 73(14):767-86. PubMed ID: 6122191
    [Abstract] [Full Text] [Related]

  • 19. [Clinical observation on acupoint catgut embedding therapy for treatment of ulcerative colitis].
    Li HJ, Li GP, Li HY.
    Zhongguo Zhen Jiu; 2006 Apr 02; 26(4):261-3. PubMed ID: 16642612
    [Abstract] [Full Text] [Related]

  • 20. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM, Greenberg GR.
    Am J Gastroenterol; 1988 Jan 02; 83(1):15-9. PubMed ID: 2892391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.